Biomedical Research Must Change — But a Shift Toward Human-specific Research Methods Is Only Part of What Is Needed

US Environmental Protection Agency. EPA directive to prioritize efforts to reduce animal testing, https://www.epa.gov/sites/production/files/2019-09/documents/image2019-09-09-231249.pdf (2019, accessed 15 June 2021).

FDA. FDA’s predictive toxicology roadmap. Silver Spring, MD: US Food and Drug Administration, 2017, 13 pp.

FDA. Advancing new alternative methodologies at FDA. Silver Spring, MD: US Food and Drug Administration, 2021, 31 pp.

Basketter DA Clewell H Kimber I , et al. A roadmap for the development of alternative (non-animal) methods for systemic toxicity testing. ALTEX 2012; 29: 3–91.

National Research Council; Committee on Toxicity and Assessment of Environmental Agents. Toxicity Testing in the 21st Century: A Vision and a Strategy. Washington DC: The National Academies Press, 2007, 216 pp.

Netherlands National Committee for the Protection of Animals Used for Scientific Purposes. NCad opinion transition to non-animal research, https://www.ncadierproevenbeleid.nl/documenten/rapport/2016/12/15/ncad-opinion-transition-to-non-animal-research (2016, accessed 15 June 2021).

Medicines Discovery Catapult and the UK Bioindustry Association. State of the discovery nation 2019, https://md.catapult.org.uk/resources/state-of-the-discovery-nation-2019/ (2019, accessed 15 June 2021).

Innovate UK. A non-animal technologies roadmap for the UK: advancing predictive biology. Swindon: Innovate UK, 2015, 19 pp.

Center for Accountability in Science. Common research problems, https://accountablescience.com/issues/evaluating-research/common-research-problems/ (2013, accessed 15 June 2021).

Feighery L . Opinion: academic waste, https://www.the-scientist.com/opinion/opinion-academic-waste-38547 (2013, accessed 15 June 2021).

Biagioli M . Watch out for cheats in citation game. Nature 2016; 535: 201.

Vaesen K Katzav J . How much would each researcher receive if competitive government research funding were distributed equally among researchers. PLoS One 2017; 12: e0183967.

Belluz J Plumer B Resnick B . The 7 biggest problems facing science, according to 270 scientists, https://www.vox.com/2016/7/14/12016710/science-challeges-research-funding-peer-review-process (2016, accessed 15 June 2021).

Smaldino PE McElreath R . The natural selection of bad science. R Soc Open Sci 2016; 3: 160384.

Ioannidis JP . More time for research: fund people not projects. Nature 2011; 477: 529–531.

Charlton BG Andras P . The future of ‘pure’ medical science: the need for a new specialist professional research system. Med Hypotheses 2005; 65: 419–425.

Bailey J Balls M . Clinical impact of high-profile animal-based research reported in the UK national press. BMJ Open Science 2020; 4: e100039.

Pippin JJ Cavanaugh SE Pistollato F . Animal research for Alzheimer disease: failures of science and ethics. In: Herrmann K Jayne K (eds) Animal experimentation: working towards a paradigm change. Boston, MA: Brill, 2019, pp. 480–516.

Pistollato F Ohayon EL Lam A , et al. Alzheimer disease research in the 21st century: past and current failures, new perspectives and funding priorities. Oncotarget 2016; 7: 38999–39016.

Pediaditakis I Kodella KR Manatakis DV , et al. Modeling alpha-synuclein pathology in a human brain-chip to assess blood–brain barrier disruption in Parkinson’s disease. bioRxiv 2020; 2020.07.22.207340.

Rõlova T Lehtonen Š Goldsteins G , et al. Metabolic and immune dysfunction of glia in neurodegenerative disorders: focus on iPSC models. Stem Cells 2020; 39: 256–265.

Bailey J Taylor K . Non-human primates in neuroscience research: the case against its scientific necessity. Altern Lab Anim 2016; 44: 43–69.

Corvi R Madia F Guyton KZ , et al. Moving forward in carcinogenicity assessment: report of an EURL ECVAM/ESTIV workshop. Toxicol In Vitro 2017; 45: 278–286.

Jacobs MN Colacci A Corvi R , et al. Chemical carcinogen safety testing: OECD expert group international consensus on the development of an integrated approach for the testing and assessment of chemical non-genotoxic carcinogens. Arch Toxicol 2020; 94: 2899–2923.

Bailey J Balls M . Recent efforts to elucidate the scientific validity of animal-based drug tests by the pharmaceutical industry, pro-testing lobby groups, and animal welfare organisations. BMC Med Ethics 2019; 20: 16.

Goyal NA Berry JD Windebank A , et al. Addressing heterogeneity in amyotrophic lateral sclerosis clinical trials. Muscle Nerve 2020; 62: 156–166.

Masrori P Van Damme P . Amyotrophic lateral sclerosis: a clinical review. Eur J Neurol 2020; 27: 1918–1929.

Bailey J . An assessment of the role of chimpanzees in AIDS vaccine research. Altern Lab Anim 2008; 36: 381–428.

Bailey J . Translatability of NHP research and testing to the development of HIV/AIDS vaccines. Sci Rep 2021 [In press].

Seok J Warren HS Cuenca AG , et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci USA 2013; 110: 3507–3512.

Stevens ML . Medical philanthropy pays dividends: the impact of philanthropic funding of basic and clinical research goes beyond mere finances by reshaping the whole research enterprise. EMBO Rep 2019; 20: e48173.

Schekman R Riley EA . Coordinating a new approach to basic research into Parkinson’s disease. Elife 2019; 8: e51167.

Bluestone JA Beier D Glimcher LH . The NIH is in danger of losing its edge in creating biomedical innovations, https://www.statnews.com/2018/01/03/nih-biomedical-research-funding/ (2018, accessed 15 June 2021).

Briggs L . A great opportunity for medical research philanthropy: fund Team Science, https://philanthropynewsdigest.org/commentary-and-opinion/fund-team-science (2012, accessed 15 June 2021).

Kiley R Peatfield T Hansen J , et al. Data sharing from clinical trials — a research funder’s perspective. N Engl J Med 2017; 377: 1990–1992.